27.65
前日終値:
$28.39
開ける:
$28.25
24時間の取引高:
1.09M
Relative Volume:
1.16
時価総額:
$2.82B
収益:
-
当期純損益:
$-804.34M
株価収益率:
-2.9384
EPS:
-9.41
ネットキャッシュフロー:
$-531.06M
1週間 パフォーマンス:
-3.12%
1か月 パフォーマンス:
-24.33%
6か月 パフォーマンス:
-45.78%
1年 パフォーマンス:
-49.44%
Biohaven Ltd Stock (BHVN) Company Profile
BHVN を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
BHVN
Biohaven Ltd
|
27.65 | 2.82B | 0 | -804.34M | -531.06M | -9.41 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
492.69 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
637.36 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
589.15 | 35.93B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
268.46 | 34.75B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
267.39 | 28.24B | 3.81B | -644.79M | -669.77M | -6.24 |
Biohaven Ltd Stock (BHVN) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-02-11 | 開始されました | Deutsche Bank | Buy |
2024-09-16 | 開始されました | Jefferies | Buy |
2024-09-04 | 開始されました | Bernstein | Outperform |
2024-07-24 | 開始されました | Morgan Stanley | Overweight |
2024-02-16 | 開始されました | RBC Capital Mkts | Outperform |
2024-02-06 | 開始されました | UBS | Buy |
2023-12-22 | 開始されました | H.C. Wainwright | Buy |
2023-12-08 | 開始されました | Robert W. Baird | Outperform |
2023-01-24 | 開始されました | SVB Securities | Outperform |
2023-01-04 | 開始されました | JP Morgan | Overweight |
2022-12-02 | 開始されました | BTIG Research | Buy |
2022-10-26 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
2022-10-12 | 開始されました | Piper Sandler | Overweight |
2022-08-19 | ダウングレード | Piper Sandler | Overweight → Neutral |
2022-08-08 | ダウングレード | Wedbush | Outperform → Neutral |
2022-05-11 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
2021-10-19 | 再開されました | Morgan Stanley | Equal-Weight |
2021-08-10 | ダウングレード | UBS | Buy → Neutral |
2021-08-03 | 繰り返されました | Canaccord Genuity | Buy |
2021-03-11 | 開始されました | UBS | Buy |
2020-12-15 | 開始されました | H.C. Wainwright | Buy |
2020-04-17 | 開始されました | Cowen | Outperform |
2020-02-10 | ダウングレード | Oppenheimer | Outperform → Perform |
2020-02-06 | 開始されました | Mizuho | Buy |
2019-11-22 | 開始されました | Wedbush | Outperform |
2019-06-25 | 繰り返されました | Canaccord Genuity | Buy |
2019-05-06 | 開始されました | Goldman | Buy |
2019-04-09 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
2019-03-04 | 繰り返されました | Needham | Buy |
2018-07-03 | 繰り返されました | Needham | Buy |
2018-07-02 | 繰り返されました | Needham | Buy |
2018-04-05 | ダウングレード | Barclays | Overweight → Equal Weight |
2018-02-22 | 繰り返されました | Canaccord Genuity | Buy |
2017-12-15 | 開始されました | Canaccord Genuity | Buy |
2017-10-03 | 繰り返されました | Needham | Buy |
すべてを表示
Biohaven Ltd (BHVN) 最新ニュース
Biohaven stock hits 52-week low at $26.7 amid market challenges - Investing.com Australia
Focal Epilepsy Market: Analysis of Epidemiology, Pipeline - openPR
Biohaven Ltd. (NYSE:BHVN) Shares Sold by Amundi - Defense World
Major Player in the Multiple System Atrophy (MSA) Market - openPR
Multiple System Atrophy Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | Ionis Pharma, Biohaven Pharma, Lundbeck A/S, Alterity Therapeutics, Theravance Biopharma, Ionis Pharma - Barchart
Multiple System Atrophy Market to Reach New Heights in Growth - openPR
Immunovant data positive for Biohaven, says Deutsche Bank - TipRanks
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Biohaven Ltd. (BHVN) and Encourages Shareholders to Learn More About the Investigation - Markets Insider
How To Trade (BHVN) - Stock Traders Daily
Biohaven’s 47% decline validates InvestingPro’s bearish Fair Value call By Investing.com - Investing.com Australia
SEC Form DEF 14A filed by Biohaven Ltd. - Quantisnow
Spinocerebellar Ataxias Pipeline 2025: Therapies, MOA - openPR
Charles Schwab Investment Management Inc. Increases Stock Holdings in Biohaven Ltd. (NYSE:BHVN) - Defense World
Biohaven Ltd. Being Investigated on Behalf of Biohaven Ltd. Investors. Contact Levi & Korsinsky For Details - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven LtdBHVN - PR Newswire
US Bancorp DE Raises Stock Position in Biohaven Ltd. (NYSE:BHVN) - Defense World
Bronstein, Gewirtz & Grossman, LLC Is Investigating Biohaven Ltd. (BHVN) And Encourages Shareholders to Connect - Markets Insider
Biohaven Ltd. Under Investigation: Levi & Korsinsky Probes Potential Securities Violations - Apna Kal
Investors who lost money on Biohaven Ltd. should contact Levi & Korsinsky about an ongoing investigationBHVN - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Biohaven Ltd. (BHVN) And Encourages Investors to Connect - Markets Insider
Biohaven Ltd. (NYSE:BHVN) Shares Bought by Bank of New York Mellon Corp - Defense World
Unpartnered Obesity Assets Are Becoming Slim Pickings For Pharma - Citeline News & Insights
Bronstein, Gewirtz & Grossman, LLC Encourages Biohaven Ltd. (BHVN) Stockholders to Inquire about Securities Investigation - Markets Insider
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Biohaven Ltd. (BHVN) and Encourages Investors to Learn More About the Investigation - Markets Insider
Biohaven Ltd. (NYSE:BHVN) Receives Consensus Recommendation of “Buy” from Brokerages - Defense World
Biohaven Ltd. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Biohaven Ltd. (BHVN) - ACCESS Newswire
Biohaven Ltd. (BHVN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Markets Insider
ATTENTION Biohaven Ltd. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights - ACCESS Newswire
Positive Outlook for Biohaven Ltd. Amid Promising Developments and FDA Priority Review - TipRanks
Independent Director of Biohaven John Childs Buys More Stock - Simply Wall St
Biohaven Ltd. (BHVN): Among Stocks with Heavy Insider Buying in 2025 - Insider Monkey
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Biohaven Ltd. (BHVN) and Encourages Stockholders to Learn More About the Investigation - Markets Insider
Biohaven Ltd. Investigated by Shareholder Rights AdvocatesInvestors Should Contact Levi & Korsinsky Regarding Potential Securities Law ViolationsBHVN - ACCESS Newswire
Morgan Stanley Lowers Biohaven (NYSE:BHVN) Price Target to $63.00 - Defense World
How to Take Advantage of moves in (BHVN) - Stock Traders Daily
Empowering women in STEM: Navigating CMC regulatory affairs -March 08, 2025 at 04:31 am EST - Marketscreener.com
Bronstein, Gewirtz & Grossman, LLC Encourages Biohaven Ltd. (BHVN) Investors to Inquire about Securities Investigation - Markets Insider
Biohaven price target lowered to $63 from $69 at Morgan Stanley - Yahoo Finance
Piper Sandler maintains Biohaven stock with $76 target - Investing.com India
Biohaven Ltd. (NYSE:BHVN) Shares Sold by Private Advisor Group LLC - Defense World
JPMorgan Chase & Co. Lowers Biohaven (NYSE:BHVN) Price Target to $68.00 - Defense World
Biohaven FY2025 EPS Forecast Reduced by Cantor Fitzgerald - Defense World
Morgan Stanley cuts Biohaven stock price target to $63 from $69 By Investing.com - Investing.com South Africa
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Biohaven Ltd. (BHVN) And Encourages Investors to Reach Out - Markets Insider
Morgan Stanley cuts Biohaven stock price target to $63 from $69 - Investing.com India
Optimistic Buy Rating for Biohaven Ltd. Amid Promising Drug Developments and Strategic Pipeline Advancements - TipRanks
Royal Bank of Canada Reaffirms “Outperform” Rating for Biohaven (NYSE:BHVN) - Defense World
HC Wainwright Reiterates Buy Rating for Biohaven (NYSE:BHVN) - Defense World
Director Makes Major Move with Biohaven Ltd. Stock Purchase - TipRanks
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Biohaven Ltd. (BHVN) And Encourages Stockholders to Reach Out - Markets Insider
Biohaven director John Childs acquires shares worth $996,238 By Investing.com - Investing.com South Africa
Biohaven Ltd (BHVN) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):